Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapsone for COVID-19 Treatment
NCT04935476Phase 3Unknown
- Sponsor
- McGill University Health Centre
- Start
- Nov 2021
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of dapsone in coronavirus disease 2019 (COVID-19), sponsored by McGill University Health Centre. Status: unknown.
02
Drugs
dapsone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04935476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04935476.